🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a single-center, randomized, open, single-dose, three-cycle cross-d...
Status
Completed
Location
Shanghai Xuhui District Central Hospital
Start Date
2018-04-02
Trial ID
NCT03483259
Treatments Being Tested
An open-label, multicenter, single-dose, single-period, sequential study to...
Status
Completed
Location
Orange County Research Center
Start Date
2021-02-12
Trial ID
NCT04755088
Treatments Being Tested
To evaluate the efficacy of Surufatnib combined with Toripalimab compared w...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2021-09-18
Trial ID
NCT05015621
Treatments Being Tested
A phase II study to assess the efficacy and safety of Surufatinib combined ...
Status
Unknown
Location
China, Fujian
Start Date
2021-10-13
Trial ID
NCT04764006
Treatments Being Tested
A phase II, muti-cohort study to assess the efficacy and safety of Surufati...
Status
Unknown
Location
Multiple Locations
Start Date
2021-03
Trial ID
NCT04734249
Treatments Being Tested
This is a phase II, single arm, open-label, multicenter study to evaluate t...
Status
Completed
Location
Beijing Cancer Hospital
Start Date
2019-12-26
Trial ID
NCT04169672
Treatments Being Tested
This study is designed to evaluate the efficacy and safety of the combinati...
Status
Unknown
Location
270 Dongan Road, Fudan University Shanghai Cancer Center
Start Date
2020-10-01
Trial ID
NCT04524884
Treatments Being Tested
This is a Phase 2, open-label, multi-centre study of surufatinib in patient...
Status
Terminated
Location
University of Alabama, Birmingham (UAB)
Start Date
2021-08-13
Trial ID
NCT04579679
Treatments Being Tested
Neuroendocrine neoplams (NENs) are uncommon, but with a significant increas...
Status
Unknown
Location
Rui Liu
Start Date
2022-07-01
Trial ID
NCT05627427
Treatments Being Tested
A Real-World Study of Durvalumab combined with Surufatinib as maintenance t...
Status
Unknown
Location
Anshan Cancer Hospital
Start Date
2024-02-15
Trial ID
NCT06255262
Treatments Being Tested